scholarly journals A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein

2001 ◽  
Vol 355 (3) ◽  
pp. 879-879
Author(s):  
H. H. VERSTEEG ◽  
E. NIJHUIS ◽  
G. R. VAN DEN BRINK ◽  
M. EVERTZEN ◽  
G. N. PYNAERT ◽  
...  
2000 ◽  
Vol 350 (3) ◽  
pp. 717-722 ◽  
Author(s):  
Henri H. VERSTEEG ◽  
Evert NIJHUIS ◽  
Gijs R. VAN DEN BRINK ◽  
Maaike EVERTZEN ◽  
Gwenda N. PYNAERT ◽  
...  

Assaying activation of signal transduction is laborious and does not allow the study of large numbers of samples, essential for high-throughput drug screens or for large groups of patients. Using phosphospecific antibodies, we have developed ELISA techniques enabling non-radioactive semi-quantitative assessment of the activation state of p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and the transcription factor cAMP-response-element-binding protein (CREB) in 96-well plates. This assay has been termed PACE (phosphospecific antibody cell-based ELISA) and was used successfully for both adherent and suspension cells. Various stimuli induced dose-dependent enzymic activity of which the kinetics closely correlated with those measured via classical methodology. Using PACE we have now characterized for the first time the concentration-dependent effects of various inflammatory prostaglandins on CREB phosphorylation in macrophages. PACE is a straightforward and novel technique enabling the large-scale analysis of signal transduction.


2000 ◽  
Vol 275 (15) ◽  
pp. 10761-10766 ◽  
Author(s):  
Subbiah Pugazhenthi ◽  
Albina Nesterova ◽  
Carol Sable ◽  
Kim A. Heidenreich ◽  
Linda M. Boxer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document